Zacks Investment Research
07 Jul 2026, 12:41 UTC · 2h ago
Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
07 Jul 2026, 12:41 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Profound Medical (PROF) shares rose 8.2% in the last session on elevated trading volume. — Short-term price momentum and high volume typically indicate increased investor interest and potential for further volatility.
+0.30Profound Medical's revenues are expected to grow 153.4% year-over-year to $5.6 million in the upcoming report. — Significant top-line growth is a positive fundamental signal, though offset by expected losses.
+0.20Profound Medical is expected to report a quarterly loss of $0.22 per share, a 57.7% increase in losses year-over-year. — Widening losses can weigh on sentiment despite revenue growth, especially in small-cap medtech.
-0.20Continue reading
6 related stories
Top 1 mover · tap to explore
The consensus EPS estimate for Profound Medical has remained unchanged over the last 30 days. — The lack of positive earnings revisions suggests the recent price jump may lack a fundamental catalyst to sustain a long-term trend.
Which stocks this story touches
Shares soared 8.2% due to momentum buying and strong sentiment regarding commercial execution and clinical progress.
Stock closed 1.5% higher with a modest 2.9% gain over the past month.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Globe News Wire
7h ago
